Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | POLB | P06746 | 2/20 | 0.72 |
| ▸ | POLA1 | P09884 | 1/20 | 0.67 |
| ▸ | POLD1 | P28340 | 1/20 | 0.67 |
| ▸ | DTYMK | P23919 | 4/20 | 0.64 |
| ▸ | TYMS | P04818 | 1/20 | 0.62 |
| ▸ | TK1 | P04183 | 3/20 | 0.61 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6839682 | 0.96 | POLB (0.77) | POLBPOLA1POLD1DTYMKTYMS | |
| Deoxythymidine_Triphosphate SCHEMBL14279191 | 0.94 | POLB (0.78) | POLBPOLA1POLD1DTYMKTYMS | |
| Deoxythymidine_Triphosphate SCHEMBL21275938 | 0.94 | POLB (0.78) | POLBPOLA1POLD1DTYMKTYMS | |
| SCHEMBL887725 | 0.94 | POLB (0.78) | POLBPOLA1POLD1DTYMKTYMS | |
| Deoxythymidine_Triphosphate SCHEMBL11055949 | 0.94 | POLB (0.78) | POLBPOLA1POLD1DTYMKTYMS | |
| Deoxythymidine_Triphosphate SCHEMBL77831 | 0.94 | POLB (0.78) | POLBPOLA1POLD1DTYMKTYMS | |
| Deoxythymidine_Triphosphate SCHEMBL18785124 | 0.94 | POLB (0.78) | POLBPOLA1POLD1DTYMKTYMS | |
| SCHEMBL21682516 | 0.94 | POLB (0.78) | POLBPOLA1POLD1DTYMKTYMS | |
| Deoxythymidine_Triphosphate SCHEMBL1579556 | 0.94 | POLB (0.78) | POLBPOLA1POLD1DTYMKTYMS | |
| Telbivudine 5'Triphosphate SCHEMBL29725270 | 0.94 | POLB (0.78) | POLBPOLA1POLD1DTYMKTYMS |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 25 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11605446-B2 | Methods and systems for determining haplotypes and phasing of haplotypes | ILLUMINA CAMBRIDGE LIMITED (GB) | 2023-03-14 | — | — | US | disclosed |
| US-20220180970-A1 | METHODS AND SYSTEMS FOR DETERMINING HAPLOTYPES AND PHASING OF HAPLOTYPES | ILLUMINA CAMBRIDGE LIMITED (GB) | 2022-06-09 | — | — | US | disclosed |
| US-20220180969-A1 | METHODS AND SYSTEMS FOR DETERMINING HAPLOTYPES AND PHASING OF HAPLOTYPES | ILLUMINA CAMBRIDGE LIMITED (GB) | 2022-06-09 | — | — | US | disclosed |
| US-11257568-B2 | Methods and systems for determining haplotypes and phasing of haplotypes | ILLUMINA CAMBRIDGE LIMITED (GB) | 2022-02-22 | — | — | US | disclosed |
| US-10428363-B2 | Amplification methods to minimise sequence specific bias | ILLUMINA CAMBRIDGE LIMITED (GB) | 2019-10-01 | — | — | US | disclosed |
| US-20180322243-A1 | METHODS AND SYSTEMS FOR DETERMINING HAPLOTYPES AND PHASING OF HAPLOTYPES | ILLUMINA CAMBRIDGE LIMITED (GB) | 2018-11-08 | — | — | US | disclosed |
| US-9977861-B2 | Methods and systems for determining haplotypes and phasing of haplotypes | ILLUMINA CAMBRIDGE LIMITED (GB) | 2018-05-22 | — | — | US | disclosed |
| EP-2875150-B1 | METHODS AND SYSTEMS FOR DETERMINING HAPLOTYPES AND PHASING OF HAPLOTYPES | ILLUMINA CAMBRIDGE LTD (GB) | 2017-05-17 | — | — | EP | disclosed |
| US-20170029857-A1 | AMPLIFICATION METHODS TO MINIMISE SEQUENCE SPECIFIC BIAS | ILLUMINA CAMBRIDGE LIMITED (GB) | 2017-02-02 | — | — | US | disclosed |
| EP-2539464-B1 | AMPLIFICATION METHODS TO MINIMISE SEQUENCE SPECIFIC BIAS | ILLUMINA INC (US) | 2016-11-16 | — | — | EP | disclosed |
| EP-2539464-A2 | AMPLIFICATION METHODS TO MINIMISE SEQUENCE SPECIFIC BIAS | Illumina, Inc. (US) | 2013-01-02 | — | — | EP | disclosed |
| WO-2011106368-A2 | AMPLIFICATION METHODS TO MINIMISE SEQUENCE SPECIFIC BIAS | ILLUMINA, INC. (US) | 2011-09-01 | — | — | WO | disclosed |
| EP-1879906-A4 | REVERSIBLE NUCLEOTIDE TERMINATORS AND USES THEREOF | ADVANCED GENETIC ANALYSIS CORP (US) | 2009-07-22 | — | — | EP | disclosed |
| EP-1879906-A2 | REVERSIBLE NUCLEOTIDE TERMINATORS AND USES THEREOF | AB Advanced Genetic Analysis Corporation (US) | 2008-01-23 | — | — | EP | disclosed |
| WO-2006074351-A2 | REVERSIBLE NUCLEOTIDE TERMINATORS AND USES THEREOF | AGENCOURT PERSONAL GENOMICS (US) | 2006-07-13 | — | — | WO | disclosed |
| EP-1498497-A2 | Method of nucleic acid analysis by mass spectrometry | Cancer Research Technology Limited (GB) | 2005-01-19 | — | — | EP | disclosed |
| EP-0813609-B1 | METHOD OF NUCLEIC ACID ANALYSIS | CANCER REC TECH LTD (GB) | 2004-10-13 | — | — | EP | disclosed |
| US-6268129-B1 | MASS SPECTROMETRY OF CHARGED NUCLEIC ACID; DNA SEQUENCING | IMPERIAL CANCER RESEARCH TECHNOLOGY LIMITED (GB) | 2001-07-31 | — | — | US | disclosed |
| EP-0813609-A1 | METHOD OF NUCLEIC ACID ANALYSIS | IMPERIAL CANCER RESEARCH TECHNOLOGY LIMITED (GB) | 1997-12-29 | — | — | EP | disclosed |
| WO-1996027681-A1 | METHOD OF NUCLEIC ACID ANALYSIS | IMPERIAL CANCER RESEARCH TECHNOLOGY LIMITED (GB) | 1996-09-12 | — | — | WO | disclosed |